FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.24  |  FHIR Version n/a  User: [n/a]

786426000: Product containing only sulfabenzamide and sulfacetamide and sulfathiazole in vaginal dose form (medicinal product form)


Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2019. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3771517018 Sulfabenzamide and sulfacetamide and sulfathiazole only product in vaginal dose form en Synonym Active Entire term case insensitive SNOMED CT core module
3771518011 Product containing only sulfabenzamide and sulfacetamide and sulfathiazole in vaginal dose form (medicinal product form) en Fully specified name Active Entire term case insensitive SNOMED CT core module


2 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing only sulfabenzamide and sulfacetamide and sulfathiazole in vaginal dose form (medicinal product form) Is a Product containing sulfabenzamide and sulfacetamide and sulfathiazole in vaginal dose form (medicinal product form) true Inferred relationship Existential restriction modifier
Product containing only sulfabenzamide and sulfacetamide and sulfathiazole in vaginal dose form (medicinal product form) Has manufactured dose form Vaginal dose form true Inferred relationship Existential restriction modifier
Product containing only sulfabenzamide and sulfacetamide and sulfathiazole in vaginal dose form (medicinal product form) Count of base of active ingredient 3 false Inferred relationship Existential restriction modifier
Product containing only sulfabenzamide and sulfacetamide and sulfathiazole in vaginal dose form (medicinal product form) Is a Product containing only sulfabenzamide and sulfacetamide and sulfathiazole (medicinal product) true Inferred relationship Existential restriction modifier
Product containing only sulfabenzamide and sulfacetamide and sulfathiazole in vaginal dose form (medicinal product form) Has active ingredient Sulfabenzamide true Inferred relationship Existential restriction modifier 1
Product containing only sulfabenzamide and sulfacetamide and sulfathiazole in vaginal dose form (medicinal product form) Has active ingredient Sulfathiazole true Inferred relationship Existential restriction modifier 3
Product containing only sulfabenzamide and sulfacetamide and sulfathiazole in vaginal dose form (medicinal product form) Has active ingredient Sulfacetamide true Inferred relationship Existential restriction modifier 2
Product containing only sulfabenzamide and sulfacetamide and sulfathiazole in vaginal dose form (medicinal product form) Plays role Antibacterial therapeutic role true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely sulfabenzamide 37 milligram/1 milliliter and sulfacetamide sodium 28.6 milligram/1 milliliter and sulfathiazole 34.2 milligram/1 milliliter conventional release vaginal cream (clinical drug) Is a True Product containing only sulfabenzamide and sulfacetamide and sulfathiazole in vaginal dose form (medicinal product form) Inferred relationship Existential restriction modifier
Product containing precisely sulfabenzamide 184 milligram and sulfacetamide sodium 144 milligram and sulfathiazole 172 milligram/1 each conventional release vaginal tablet (clinical drug) Is a True Product containing only sulfabenzamide and sulfacetamide and sulfathiazole in vaginal dose form (medicinal product form) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start